FEATURED APPLICATION CONTENT

• Multi-Technique, Vendor Neutral Analytical Data Handling For Chemists

  Managing analytical data across instruments doesn’t have to slow decision-making. Learn how a vendor-neutral, multi-technique approach helps chemists access, process, and report results efficiently.

• Simplify And Streamline Method Development With In Silico Modeling

  Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

• Standardization Of Analytical Data: Best Practices

  Standardized analytical data is key to improving data quality, reuse, and AI readiness. Explore the challenges of fragmented formats and gain practical guidance on building future-proof foundations.

• Integrated Drug Discovery: Hit To PCC In 16 Months

  Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.

• Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)

  Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.

• Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging

  High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.

• A Miniaturized, Semi-Automated RNA-seq Workflow

  A streamlined RNA‑seq workflow enables high‑throughput gene expression profiling directly from cell lysates, reducing cost and complexity. See how this approach accelerates lead selection.

• Master The Art Of Pipetting And Learn How To Perform Serial Dilutions

  Accurate serial dilutions depend on more than calculations. Learn how mixing, tip handling, and workflow consistency influence accuracy, as well as how small adjustments can improve reproducibility.

• ADC Development Grows More Complex — SPR Insights Bring Clarity

  Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

• Bispecific Antibodies Unleashed

  Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies.

• Leveraging The Immunological Diversity Of The Pentamice® Platform For Covid-19 Antibody Discovery

  Consider this alternative immunization approach — the PentaMice platform, a collection of five wildtype mouse strains bred in-house for increased MHC class II diversity — and how we're leveraging it for COVID-19 antibody discovery.

• The Value Of Engaging A Single CDMO For Comprehensive Biologics Services

  By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.